Mesa Laboratories, Inc. (NASDAQ:MLAB) insider Glenn E. Adriance sold 4,000 shares of the company’s stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $148.98, for a total value of $595,920.00. Following the completion of the transaction, the insider now owns 10,000 shares in the company, valued at approximately $1,489,800. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) traded down 0.85% during midday trading on Monday, hitting $140.49. The company had a trading volume of 12,702 shares. The firm’s 50-day moving average is $146.89 and its 200-day moving average is $130.90. The firm has a market capitalization of $525.01 million, a P/E ratio of 48.28 and a beta of 0.44. Mesa Laboratories, Inc. has a 12-month low of $102.14 and a 12-month high of $169.80.
Mesa Laboratories (NASDAQ:MLAB) last posted its quarterly earnings results on Wednesday, June 7th. The medical instruments supplier reported $1.24 EPS for the quarter, topping the Zacks’ consensus estimate of $1.00 by $0.24. Mesa Laboratories had a return on equity of 17.67% and a net margin of 11.94%. The firm had revenue of $24.30 million during the quarter, compared to analyst estimates of $27.10 million. On average, analysts predict that Mesa Laboratories, Inc. will post $3.06 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Thursday, June 15th. Stockholders of record on Wednesday, May 31st were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.46%. The ex-dividend date of this dividend was Friday, May 26th. Mesa Laboratories’s payout ratio is currently 21.99%.
ILLEGAL ACTIVITY WARNING: “Mesa Laboratories, Inc. (MLAB) Insider Sells $595,920.00 in Stock” was originally published by BBNS and is the property of of BBNS. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://baseballnewssource.com/markets/mesa-laboratories-inc-mlab-insider-glenn-e-adriance-sells-4000-shares-updated/985325.html.
Separately, Zacks Investment Research cut Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, April 12th.
Mesa Laboratories Company Profile
Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.
Receive News & Ratings for Mesa Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories Inc. and related companies with our FREE daily email newsletter.